| 1. | SSR158A 20-295 PET21_NESG (IN PROGRESS) | ||||
| 2. | TAR113B 344-515 PET21_NESG (IN PROGRESS) | ||||
| 3. | MUR44D 1-276 PET21_NESG (IN PROGRESS) | ||||
| 4. | STR318-39-134-21 | ||||
| 5. | TMR34A 228-465 PET21_NESG (IN PROGRESS) | ||||
| 6. | CAR253-21 | ||||
| 7. | TMR34A 1-270 PET21_NESG (IN PROGRESS) | ||||
| 8. | CRR121-21 | ||||
| CRR121-21.5-NC5A-GF | 40.39 mg/ml | ||||
| CRR121-21.5-SEMA-GF | 37.60 mg/ml | ||||
| 9. | UHR107-21 | ||||
| 10. | STR320-21 | ||||
| 11. | CRR121-15-197-21 | ||||
| CRR121-15-197-21.3-NC5A-NI | 22.39 mg/ml | ||||
| CRR121-15-197-21.3-NC5A-GF | 23.06 mg/ml | ||||
| CRR121-15-197-21.3-NC5B-GF | 18.03 mg/ml | ||||
| CRR121-15-197-21.3-SEMA-GF | 17.16 mg/ml | ||||
| CRR121-15-197-21.3-SEMB-GF | 17.16 mg/ml | ||||
| CRR121-15-197-21.3-NC5B-NI | 17.52 mg/ml | ||||
| 12. | MUR44B 70-293 PET21_NESG (IN PROGRESS) | ||||
| 13. | MUR44B 77-275 PET21_NESG (IN PROGRESS) | ||||
| 14. | KPR99-21 | ||||
| 15. | LGR174-52-296-21 | ||||
| 16. | SSR158-21 | ||||
| 17. | HMR232-28-551-21 | ||||
| 18. | MJR149B 397-533 PET21_NESG (IN PROGRESS) | ||||
| 19. | SFR351-21 | ||||
| 20. | MUR44B 1-293 PET21_NESG (IN PROGRESS) | ||||
| 21. | WSR36-21 | ||||
| WSR36-21.8-SEMA-NI | 109.00 mg/ml | ||||
| WSR36-21.8-SEMA-GF | 21.60 mg/ml | ||||
| 22. | BOR285-21 | ||||
| BOR285-21.4-SEMA-GF | 108.00 mg/ml | ||||
| BOR285-21.4-SEMA-NI | 55.00 mg/ml | ||||
| 23. | PAR412-21 | ||||
| PAR412-21.2-NC5A-GF | 16.63 mg/ml | ||||
| PAR412-21.2-SEMA-GF | 39.20 mg/ml | ||||
| PAR412-21.2-NC5A-NI | 25.00 mg/ml | ||||
| 24. | HMR232C 390-551 PET21_NESG (IN PROGRESS) | ||||
| 25. | TAR113-17-454-21 | ||||
| 26. | TMR34A 1-298 PET21_NESG (IN PROGRESS) | ||||
| 27. | TAR113-38-454-21 | ||||
| 28. | TAR113B 355-515 PET21_NESG (IN PROGRESS) | ||||
| 29. | PAR412-8-210-21 | ||||
| PAR412-8-210-21.6-NC5A-GF | 4.13 mg/ml | ||||
| PAR412-8-210-21.6-NC5A-NI | 7.31 mg/ml | ||||
| 30. | MUR44D 70-276 PET21_NESG (IN PROGRESS) | ||||
| 31. | SSR158B 303-473 PET21_NESG (IN PROGRESS) | ||||
| 32. | ASR194-7-127-21 | ||||
| ASR194-7-127-21.1-NC5A-GF | 17.55 mg/ml | ||||
| ASR194-7-127-21.1-NC5B-GF | 27.49 mg/ml | ||||
| ASR194-7-127-21.1-NC5A-NI | 3.72 mg/ml | ||||
| ASR194-7-127-21.1-NC5B-NI | 5.82 mg/ml | ||||
| 33. | VPR283-11-193-21 | ||||
| VPR283-11-193-21.2-SEMA-GF | 49.12 mg/ml | ||||
| VPR283-11-193-21.2-NC5A-GF | 6.91 mg/ml | ||||
| 34. | BOR286-38-139-21 | ||||
| 35. | TAR113B 70-338 PET21_NESG (IN PROGRESS) | ||||
| 36. | CVR239-21 | ||||
| CVR239-21.1-SEMA-GF | 100.80 mg/ml | ||||
| CVR239-21.1-SEMA-NI | 64.00 mg/ml | ||||
| 37. | SRR207-6-121-21 | ||||
| SRR207-6-121-21.1-SEMA-GF | 9.80 mg/ml | ||||
| SRR207-6-121-21.1-NC5A-GF | 10.30 mg/ml | ||||
| 38. | RSR338-21 | ||||
| 39. | LJR59-21 | ||||
| 40. | HMR232C 1-318 PET21_NESG (IN PROGRESS) | ||||
| 41. | HMR232C 375-551 PET21_NESG (IN PROGRESS) | ||||
| 42. | MUR44D 399-511 PET21_NESG (IN PROGRESS) | ||||
| 43. | SNR212-21 | ||||
| SNR212-21.4-SEMA-GF | 45.00 mg/ml | ||||
| SNR212-21.4-NCA-GF | 30.30 mg/ml | ||||
| SNR212-21.4-NC5A-GF | 32.23 mg/ml | ||||
| SNR212-21.4-NCA-NI | 30.61 mg/ml | ||||
| SNR212-21.4-NC5B-GF | 27.04 mg/ml | ||||
| SNR212-21.4-NC5B-NI | 30.31 mg/ml | ||||
| 44. | TAR113B 70-280 PET21_NESG (IN PROGRESS) | ||||
| 45. | SSR158B 1-292 PET21_NESG (IN PROGRESS) | ||||
| 46. | VPR117-35-578-21 | ||||
| 47. | STR321-21 | ||||
| STR321-21.1-SEMB-GF | 79.20 mg/ml | ||||
| STR321-21.1-SEMB-NI | 37.80 mg/ml | ||||
| STR321-21.1-SEMA-GF | 79.20 mg/ml | ||||
| STR321-21.1-SEMA-NI | 37.80 mg/ml | ||||
| STR321-21.1-SEMC-NI | 37.80 mg/ml | ||||
| 48. | TAR113 89-515 PET21_NESG (IN PROGRESS) | ||||
| 49. | HMR232C 81-318 PET21_NESG (IN PROGRESS) | ||||
| 50. | TAR113B 1-501 PET21_NESG (IN PROGRESS) | ||||
| 51. | HMR232C 81-543 PET21_NESG (IN PROGRESS) | ||||
| 52. | NMR123-21 | ||||
| 53. | ILR61-29-601-21 | ||||
| 54. | GSR168-27-292-21 | ||||
| 55. | CPR198-6-294-21 | ||||
| 56. | MJR149B 424-541 PET21_NESG (IN PROGRESS) | ||||
| 57. | TMR34A 335-465 PET21_NESG (IN PROGRESS) | ||||
| 58. | TAR113B 1-280 PET21_NESG (IN PROGRESS) | ||||
| 59. | WSR36-1-247-21 | ||||
| WSR36-1-247-21.9-SEMA-NI | 65.60 mg/ml | ||||
| 60. | MBR320-21 | ||||
| 61. | MUR44A 107-520 PET21_NESG (IN PROGRESS) | ||||
| 62. | TMR34A 1-230 PET21_NESG (IN PROGRESS) | ||||
| 63. | HMR232 1-484 PET21_NESG (IN PROGRESS) | ||||
| 64. | UHR109-29-247-21 | ||||
| 65. | MUR44D 49-509 PET21_NESG (IN PROGRESS) | ||||
| 66. | TAR113B 70-515 PET21_NESG (IN PROGRESS) | ||||
| 67. | LBR75-21 | ||||
| 68. | SSR158B 1-296 PET21_NESG (IN PROGRESS) | ||||
| 69. | TMR34A 17-273 PET21_NESG (IN PROGRESS) | ||||
| 70. | MUR44A 55-476 PET21_NESG (IN PROGRESS) | ||||
| 71. | MJR149B 397-541 PET21_NESG (IN PROGRESS) | ||||
| 72. | PMR36-21 | ||||
| 73. | STR319-39-270-21 | ||||
| 74. | UHR109-45-247-21 | ||||
| UHR109-45-247-21.13-SEMA-GF | 23.24 mg/ml | ||||
| UHR109-45-247-21.13-NC5A-NI | 88.81 mg/ml | ||||
| UHR109-45-247-21.13-NC5A-GF | 35.70 mg/ml | ||||
| 75. | TAR113A 66-347 PET21_NESG (IN PROGRESS) | ||||
| 76. | YER85-21 | ||||
| YER85-21.2-NC5B-NI | 23.22 mg/ml | ||||
| YER85-21.2-SEMA-GF | 36.80 mg/ml | ||||
| YER85-21.2-NC5A-NI | 46.63 mg/ml | ||||
| YER85-21.2-NCA-NI | 26.76 mg/ml | ||||
| YER85-21.2-NC5A-GF | 28.77 mg/ml | ||||
| YER85-21.2-NCA-GF | 44.88 mg/ml | ||||
| YER85-21.2-NC5B-GF | 30.80 mg/ml | ||||
| 77. | PPR356-21 | ||||
| 78. | PPR356-47-247-21 | ||||
| 79. | SSR158A 10-295 PET21_NESG (IN PROGRESS) | ||||
| 80. | PAR407-35-621-21 | ||||
| 81. | PAR414-21 | ||||
| 82. | RMR120-8-222-21 | ||||
| 83. | UHR109-29-203-21 | ||||
| 84. | UHR109-29-232-21 | ||||
| 85. | HMR232 1-501 PET21_NESG (IN PROGRESS) | ||||
| 86. | TAR113A 91-347 PET21_NESG (IN PROGRESS) | ||||
| 87. | MUR44D 410-520 PET21_NESG (IN PROGRESS) | ||||
| 88. | MUR44D 410-511 PET21_NESG (IN PROGRESS) | ||||
| 89. | ILR60-21 | ||||
| 90. | MR152-21 | ||||
| 91. | PMR36-1-260-21 | ||||
| 92. | BTR288-21 | ||||
| BTR288-21.2-SEMA-NI | 45.00 mg/ml | ||||
| BTR288-21.2-SEMB-NI | 45.00 mg/ml | ||||
| 93. | SNR212-6-122-21 | ||||
| SNR212-6-122-21.1-NC5B-GF | 39.15 mg/ml | ||||
| SNR212-6-122-21.1-NC5A-NI | 19.70 mg/ml | ||||
| SNR212-6-122-21.1-NC5B-NI | 29.94 mg/ml | ||||
| SNR212-6-122-21.1-NC5A-GF | 25.78 mg/ml | ||||
| 94. | RMR120-32-199-21 | ||||
| 95. | TAR113-17-515-21 | ||||
| TAR113-17-515-21.7-SEM-R3-GF | 3.10 mg/ml | ||||
| TAR113-17-515-21.7-SEM-R2-GF | 3.10 mg/ml | ||||
| TAR113-17-515-21.7-SEM-R1-GF | 3.10 mg/ml | ||||
| 96. | MUR44A 67-520 PET21_NESG (IN PROGRESS) | ||||
| 97. | VR149-21 | ||||
| 98. | CRR120-30-640-21 | ||||
| 99. | RMR120-8-199-21 | ||||
| RMR120-8-199-21.12-SEMB-NI | 51.00 mg/ml | ||||
| RMR120-8-199-21.12-SEMA-NI | 51.00 mg/ml | ||||
| RMR120-8-199-21.12-SEMB-GF | 41.40 mg/ml | ||||
| RMR120-8-199-21.12-SEMA-GF | 41.40 mg/ml | ||||
| RMR120-8-199-21.12-SEMC-GF | 41.40 mg/ml | ||||
| RMR120-8-199-21.12-SEMC-NI | 51.00 mg/ml | ||||
| 100. | MJR149A 96-362 PET21_NESG (IN PROGRESS) | ||||
| 101. | MUR44A 92-520 PET21_NESG (IN PROGRESS) | ||||
| 102. | MUR44D 380-520 PET21_NESG (IN PROGRESS) | ||||
| 103. | TDR120-21 | ||||
| 104. | WSR36-56-278-21 | ||||
| WSR36-56-278-21.5-SEMA-GF | 67.20 mg/ml | ||||
| WSR36-56-278-21.5-SEMA-NI | 73.20 mg/ml | ||||
| 105. | SSR158B 288-473 PET21_NESG (IN PROGRESS) | ||||
| 106. | GSR168-21 | ||||
| GSR168-21.7-SEMA-NI | 34.20 mg/ml | ||||
| GSR168-21.1-SEMA-GF | 12.60 mg/ml | ||||
| GSR168-21.7-SEMB-GF | 19.20 mg/ml | ||||
| GSR168-21.7-SEMA-GF | 6.00 mg/ml | ||||
| GSR168-21.7-SEMC-GF | 19.20 mg/ml | ||||
| 107. | MUR44D 399-520 PET21_NESG (IN PROGRESS) | ||||
| 108. | YER84-40-134-21 | ||||
| 109. | MUR44B 92-306 PET21_NESG (IN PROGRESS) | ||||
| 110. | TAR113A 66-355 PET21_NESG (IN PROGRESS) | ||||
| 111. | GMR256-56-549-21 | ||||
| 112. | PAR411-10-125-21 | ||||
| PAR411-10-125-21.9-NC5A-NI | 2.88 mg/ml | ||||
| PAR411-10-125-21.9-SEMA-GF | 16.10 mg/ml | ||||
| 113. | RMR120-21 | ||||
| 114. | TMR34A 1-288 PET21_NESG (IN PROGRESS) | ||||
| 115. | HMR232A 117-551 PET21_NESG (IN PROGRESS) | ||||
| 116. | VCR249-21 | ||||
| VCR249-21.1-NC5A-GF | 40.04 mg/ml | ||||
| VCR249-21.1-SEMA-GF | 14.04 mg/ml | ||||
| 117. | MUR44A 55-520 PET21_NESG (IN PROGRESS) | ||||
| 118. | UHR109-51-247-21 | ||||
| 119. | PPR120-21-420-21 | ||||
| 120. | CPR198-29-294-21 | ||||
| CPR198-29-294-21.3-SEMA-NI | 42.00 mg/ml | ||||
| CPR198-29-294-21.3-SEMB-NI | 42.00 mg/ml | ||||
| 121. | MUR44B 1-275 PET21_NESG (IN PROGRESS) | ||||
| 122. | TAR113 1-469 PET21_NESG (IN PROGRESS) | ||||
| 123. | TAR113B 327-515 PET21_NESG (IN PROGRESS) | ||||
| 124. | CMR123-21 | ||||
| CMR123-21.2-SEMA-GF | 54.40 mg/ml | ||||
| CMR123-21.2-SEMA-NI | 74.40 mg/ml | ||||
| 125. | MJR149-21 | ||||
| MJR149-21.1-SEM-R3-GF | 72.00 mg/ml | ||||
| MJR149-21.1-SEM-R2-GF | 72.00 mg/ml | ||||
| MJR149-21.1-SEM-R1-GF | 72.00 mg/ml | ||||
| 126. | MUR44B 55-292 PET21_NESG (IN PROGRESS) | ||||
| 127. | RMR120-32-222-21 | ||||
| 128. | TDR120-21-374-21 | ||||
| 129. | UHR110-21 | ||||
| 130. | CAR253-30-143-21 | ||||
| 131. | ATR381-21 | ||||
| 132. | ER692-21 | ||||
| 133. | PLR75-49-583-21 | ||||
| 134. | WSR36-1-272-21 | ||||
| WSR36-1-272-21.4-SEMA-GF | 17.60 mg/ml | ||||
| WSR36-1-272-21.4-SEMA-NI | 120.00 mg/ml | ||||
| 135. | SPR106-21 | ||||
| SPR106-21.2-SEMA-NI | 52.80 mg/ml | ||||
| SPR106-21.2-SEMA-GF | 18.90 mg/ml | ||||
| SPR106-21.2-SEMB-GF | 18.90 mg/ml | ||||
| SPR106-21.2-SEMB-NI | 52.80 mg/ml | ||||
| 136. | TAR113B 355-501 PET21_NESG (IN PROGRESS) | ||||
| 137. | RMR120-1-199-21 | ||||
| RMR120-1-199-21.3-SEMA-GF | 8.80 mg/ml | ||||
| RMR120-1-199-21.3-NC5A-NI | 5.83 mg/ml | ||||
| RMR120-1-199-21.3-NC5A-GF | 2.57 mg/ml | ||||
| 138. | TAR113A 81-332 PET21_NESG (IN PROGRESS) | ||||
| 139. | MUR44B 65-306 PET21_NESG (IN PROGRESS) | ||||
| 140. | MJR149A 96-350 PET21_NESG (IN PROGRESS) | ||||
| 141. | SUR105-21 | ||||
| SUR105-21.1-SEMB-NI | 28.80 mg/ml | ||||
| SUR105-21.1-SEMA-NI | 28.80 mg/ml | ||||
| 142. | MUR44B 107-293 PET21_NESG (IN PROGRESS) | ||||
| 143. | TER258-6-126-21 | ||||
| TER258-6-126-21.2-NCA-GF | 39.70 mg/ml | ||||
| TER258-6-126-21.2-SEMA-GF | 19.60 mg/ml | ||||
| TER258-6-126-21.2-NCA-NI | 38.80 mg/ml | ||||
| TER258-6-126-21.2-NC5B-NI | 35.55 mg/ml | ||||
| TER258-6-126-21.2-NC5A-NI | 109.73 mg/ml | ||||
| TER258-6-126-21.2-NC5A-GF | 55.58 mg/ml | ||||
| 144. | SUR75-21 | ||||
| 145. | BUR278-21 | ||||
| 146. | TMR34A 17-285 PET21_NESG (IN PROGRESS) | ||||
| 147. | MUR44B 1-306 PET21_NESG (IN PROGRESS) | ||||
| 148. | MUR44D 395-511 PET21_NESG (IN PROGRESS) | ||||
| 149. | ILR61-25-601-21 | ||||
| 150. | MJR149A 81-375 PET21_NESG (IN PROGRESS) | ||||
| 151. | TMR34B 227-465 PET21_NESG (IN PROGRESS) | ||||
| 152. | MUR44B 107-275 PET21_NESG (IN PROGRESS) | ||||
| 153. | UCR130-42-141-21 | ||||
| 154. | PAR413-21 | ||||
| 155. | VPR283-21 | ||||
| VPR283-21.3-NC5A-GF | 47.78 mg/ml | ||||
| VPR283-21.3-SEMA-GF | 49.68 mg/ml | ||||
| 156. | WSR36-83-278-21 | ||||
| WSR36-83-278-21.1-NC5A-GF | 62.53 mg/ml | ||||
| WSR36-83-278-21.1-SEMA-GF | 78.10 mg/ml | ||||
| 157. | TAR113-38-515-21 | ||||
| 158. | CRR121-37-197-21 | ||||
| 159. | UHR109-1-227-21 | ||||
| 160. | MJR149B 94-302 PET21_NESG (IN PROGRESS) | ||||
| 161. | SRR207-1-125-21 | ||||
| SRR207-1-125-21.5-NC5A-GF | 3.33 mg/ml | ||||
| SRR207-1-125-21.5-SEMA-GF | 43.36 mg/ml | ||||
| 162. | TAR113B 402-515 PET21_NESG (IN PROGRESS) | ||||
| 163. | HMR232C 81-551 PET21_NESG (IN PROGRESS) | ||||
| 164. | SSR158A 8-308 PET21_NESG (IN PROGRESS) | ||||
| 165. | PAR412-25-210-21 | ||||
| 166. | PGR141-21 | ||||
| PGR141-21.1-SEMA-GF | 84.00 mg/ml | ||||
| PGR141-21.1-SEMA-NI | 60.00 mg/ml | ||||
| 167. | RSR338-19-208-21 | ||||
| 168. | SSR158A 1-308 PET21_NESG (IN PROGRESS) | ||||
| 169. | UHR107-1-621-21 | ||||
| 170. | SSR158B 10-292 PET21_NESG (IN PROGRESS) | ||||
| 171. | TAR113A 89-355 PET21_NESG (IN PROGRESS) | ||||
| 172. | UHR109-21 | ||||
| 173. | UHR109-45-227-21 | ||||
| 174. | TAR113-1-454-21 | ||||
| 175. | MUR44-21 | ||||
| 176. | SRR207-6-125-21 | ||||
| SRR207-6-125-21.4-SEMA-GF | 48.06 mg/ml | ||||
| SRR207-6-125-21.4-NC5A-NI | 46.31 mg/ml | ||||
| SRR207-6-125-21.4-SEMB-GF | 48.06 mg/ml | ||||
| SRR207-6-125-21.4-NC5A-GF | 48.72 mg/ml | ||||
| 177. | GMR256-56-505-21 | ||||
| 178. | TAR113B 402-501 PET21_NESG (IN PROGRESS) | ||||
| 179. | ASR194-21 | ||||
| 180. | PR148-21 | ||||
| 181. | MUR44D 384-520 PET21_NESG (IN PROGRESS) | ||||
| 182. | MUR44B 55-306 PET21_NESG (IN PROGRESS) | ||||
| 183. | UHR109-51-232-21 | ||||
| 184. | CRR120-37-640-21 | ||||
| 185. | RMR120-13-222-21 | ||||
| 186. | PTR7-21 | ||||
| PTR7-21.4-SEMB-GF | 61.60 mg/ml | ||||
| PTR7-21.4-SEMA-GF | 61.60 mg/ml | ||||
| 187. | SSR158A 1-300 PET21_NESG (IN PROGRESS) | ||||
| 188. | MUR44A 98-520 PET21_NESG (IN PROGRESS) | ||||
| 189. | CPR198-21 | ||||
| 190. | HMR232B 28-377 PET21_NESG (IN PROGRESS) | ||||
| 191. | SSR158A 1-283 PET21_NESG (IN PROGRESS) | ||||
| 192. | MQR201-21 | ||||
| 193. | BER215-38-139-21 | ||||
| 194. | TAR113-21 | ||||
| 195. | PAR414-1-155-21 | ||||
| 196. | SSR158B 318-473 PET21_NESG (IN PROGRESS) | ||||
| 197. | MJR149A 81-365 PET21_NESG (IN PROGRESS) | ||||
| 198. | RLR273-12-362-21 | ||||
| 199. | MJR149B 408-541 PET21_NESG (IN PROGRESS) | ||||
| 200. | ILR60-1-575-21 | ||||
| 201. | MUR44A 65-476 PET21_NESG (IN PROGRESS) | ||||
| 202. | TER258-21 | ||||
| TER258-21.4-NC5B-GF | 55.46 mg/ml | ||||
| TER258-21.4-SEMA-GF | 30.38 mg/ml | ||||
| TER258-21.4-NC5A-NI | 79.69 mg/ml | ||||
| TER258-21.4-SEMB-GF | 30.38 mg/ml | ||||
| TER258-21.4-NC5A-GF | 53.28 mg/ml | ||||
| TER258-21.4-NC5B-NI | 82.94 mg/ml | ||||
| 203. | VCR250-53-284-21 | ||||
| VCR250-53-284-21.1-SEMA-NI | 118.20 mg/ml | ||||
| VCR250-53-284-21.1-SEMA-GF | 70.00 mg/ml | ||||
| 204. | MUR44A 82-520 PET21_NESG (IN PROGRESS) | ||||
| 205. | HMR232-21 | ||||
| 206. | CRR120-73-640-21 | ||||
| 207. | MUR44B 98-292 PET21_NESG (IN PROGRESS) | ||||
| 208. | MUR44B 70-275 PET21_NESG (IN PROGRESS) | ||||
| 209. | TMR34A 347-465 PET21_NESG (IN PROGRESS) | ||||
| 210. | PPR357-21 | ||||
| PPR357-21.1-NC5A-GF | 22.50 mg/ml | ||||
| PPR357-21.1-NC5A-NI | 36.14 mg/ml | ||||
| PPR357-21.1-SEMA-GF | 31.20 mg/ml | ||||
| 211. | HMR232C 1-447 PET21_NESG (IN PROGRESS) | ||||
| 212. | CRR120-79-640-21 | ||||
| 213. | PAR414-17-155-21 | ||||
| 214. | HMR232B 35-368 PET21_NESG (IN PROGRESS) | ||||
| 215. | BOR288-21 | ||||
| 216. | DRR232-21 | ||||
| DRR232-21.1-SEMA-GF | 127.40 mg/ml | ||||
| 217. | MUR44B 77-293 PET21_NESG (IN PROGRESS) | ||||
| 218. | STR319-39-240-21 | ||||
| 219. | SAR128-21 | ||||
| 220. | TAR113B 66-338 PET21_NESG (IN PROGRESS) | ||||
| 221. | SSR158A 1-295 PET21_NESG (IN PROGRESS) | ||||
| 222. | MUR44D 395-520 PET21_NESG (IN PROGRESS) | ||||
| 223. | WSR35-21 | ||||
| WSR35-21.2-SEMA-NI | 71.00 mg/ml | ||||
| WSR35-21.2-SEMA-GF | 98.40 mg/ml | ||||
| 224. | VCR250-77-284-21 | ||||
| 225. | MUR44D 72-520 PET21_NESG (IN PROGRESS) | ||||
| 226. | SSR158A 17-283 PET21_NESG (IN PROGRESS) | ||||
| 227. | EWR247-21 | ||||
| 228. | TMR34A 1-273 PET21_NESG (IN PROGRESS) | ||||
| 229. | TMR34-21 | ||||
| 230. | VCR227-49-619-21 | ||||
| VCR227-49-619-21.4-SEMA-GF | 19.80 mg/ml | ||||
| VCR227-49-619-21.4-SEMA-NI | 37.60 mg/ml | ||||
| 231. | CRR120-105-640-21 | ||||
| CRR120-105-640-21.7-SEMA-GF | 42.00 mg/ml | ||||
| CRR120-105-640-21.7-SEMA-NI | 78.00 mg/ml | ||||
| 232. | MUR44B 65-292 PET21_NESG (IN PROGRESS) | ||||
| 233. | UHR109-1-232-21 | ||||
| 234. | MUR44B 92-292 PET21_NESG (IN PROGRESS) | ||||
| 235. | TAR113A 81-338 PET21_NESG (IN PROGRESS) | ||||
| 236. | PAR414-17-235-21 | ||||
| 237. | GSR168-22-292-21 | ||||
| 238. | LMR154-21 | ||||
| 239. | SPR105-21 | ||||
| SPR105-21.1-SEMA-GF | 143.00 mg/ml | ||||
| 240. | ILR60-1-580-21 | ||||
| 241. | VCR227-71-619-21 | ||||
| 242. | LGR173-21 | ||||
| LGR173-21.1-NC5B-GF | 24.51 mg/ml | ||||
| LGR173-21.1-NC5A-NI | 23.06 mg/ml | ||||
| LGR173-21.1-NC5B-NI | 23.06 mg/ml | ||||
| LGR173-21.1-SEMB-GF | 4.00 mg/ml | ||||
| LGR173-21.1-NC5A-GF | 24.51 mg/ml | ||||
| LGR173-21.1-SEMA-GF | 4.00 mg/ml |